Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · IEX Real-Time Price · USD
5.60
-0.01 (-0.18%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $735.13 million as of July 2, 2024. Its market cap has decreased by -32.52% in one year.
Market Cap
735.13M
Enterprise Value
474.86M
1-Year Change
-32.52%
Ranking
Category
Stock Price
$5.60
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $735.13M, a decrease of -67.48%. That is a compound annual growth rate of -31.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 736.40M | -40.43% |
| Dec 29, 2023 | 1.24B | -10.22% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CareDx | 787.51M |
| Aurinia Pharmaceuticals | 780.17M |
| HilleVax | 757.25M |
| Perspective Therapeutics | 750.16M |
| CureVac | 745.82M |
| Nuvation Bio | 742.75M |
| 89bio | 738.86M |
| The Pennant Group | 728.91M |